Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Allakos Inc. | 154,786 | reported | 01 Aug 2023 | tx 1+154,786 |
| Upstream Bio, Inc. | 72,907 | reported | 16 Mar 2026 | tx 4+800,000−2,093 |
| Krystal Biotech, Inc. | 5,000 | reported | 30 Jun 2025 | tx 5+37,200 |
| Translate Bio, Inc. | 0 | reported | 14 Sept 2021 | tx 2+300,000−300,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Mar 2026 | SALE | Upstream Bio, Inc. | 2,093 | 9.29 USD | |
| 02 Jan 2026 | GRANT_AWARD | Upstream Bio, Inc. | 75,000 | 0.00 USD | |
| 02 Jan 2026 | GRANT_AWARD | Upstream Bio, Inc. | 225,000 | 0.00 USD | deriv |
| 30 Jun 2025 | GRANT_AWARD | Krystal Biotech, Inc. | 5,000 | 0.00 USD | deriv |
| 06 Feb 2025 | GRANT_AWARD | Upstream Bio, Inc. | 500,000 | 0.00 USD | deriv |
| 30 Jun 2024 | GRANT_AWARD | Krystal Biotech, Inc. | 5,000 | 0.00 USD | deriv |
| 01 Aug 2023 | GRANT_AWARD | Allakos Inc. | 154,786 | 0.00 USD | deriv |
| 30 Jun 2023 | GRANT_AWARD | Krystal Biotech, Inc. | 6,800 | 0.00 USD | deriv |
| 30 Jun 2022 | GRANT_AWARD | Krystal Biotech, Inc. | 6,800 | 0.00 USD | deriv |
| 31 Jan 2022 | GRANT_AWARD | Krystal Biotech, Inc. | 13,600 | 0.00 USD | deriv |
| 14 Sept 2021 | SALE | Translate Bio, Inc. | 300,000 | 0.00 USD | deriv |
| 22 Mar 2021 | GRANT_AWARD | Translate Bio, Inc. | 300,000 | 0.00 USD | deriv |